Clinical Trial Update: Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating mirtazapine plus gemcitabine versus gemcitabine for metastatic pancreatic cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Remeron (mirtazapine)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Pancreatic Cancer | Phase 2, Phase 3 | Status: WITHDRAWN